361 related articles for article (PubMed ID: 33570715)
1. Systemic and Nodular Hyperinflammation in a Patient with Refractory Familial Hemophagocytic Lymphohistiocytosis 2.
Segal JE; Daley JD; Barnum JL; Salgado CM; Reyes-Mugica M; Schneider C; Gumus S; Thakrar D; Allen SW; Canna SW
J Clin Immunol; 2021 Jul; 41(5):987-991. PubMed ID: 33570715
[TBL] [Abstract][Full Text] [Related]
2. The use of anakinra in the treatment of secondary hemophagocytic lymphohistiocytosis.
Bami S; Vagrecha A; Soberman D; Badawi M; Cannone D; Lipton JM; Cron RQ; Levy CF
Pediatr Blood Cancer; 2020 Nov; 67(11):e28581. PubMed ID: 32725881
[TBL] [Abstract][Full Text] [Related]
3. Ruxolitinib for secondary hemophagocytic lymphohistiocytosis: First case report.
Sin JH; Zangardi ML
Hematol Oncol Stem Cell Ther; 2019 Sep; 12(3):166-170. PubMed ID: 28834694
[TBL] [Abstract][Full Text] [Related]
4. Profile of hemophagocytic lymphohistiocytosis; efficacy of intravenous immunoglobulin therapy.
Rajajee S; Ashok I; Manwani N; Rajkumar J; Gowrishankar K; Subbiah E
Indian J Pediatr; 2014 Dec; 81(12):1337-41. PubMed ID: 24806152
[TBL] [Abstract][Full Text] [Related]
5. Novel Therapeutic Approaches to Familial HLH (Emapalumab in FHL).
Merli P; Algeri M; Gaspari S; Locatelli F
Front Immunol; 2020; 11():608492. PubMed ID: 33424859
[TBL] [Abstract][Full Text] [Related]
6. Ruxolitinib for the treatment of lymphoma-associated hemophagocytic lymphohistiocytosis: A cautionary tale.
Trantham T; Auten J; Muluneh B; Van Deventer H
J Oncol Pharm Pract; 2020 Jun; 26(4):1005-1008. PubMed ID: 31575356
[TBL] [Abstract][Full Text] [Related]
7. Hemophagocytic lymphohistiocytosis after SARS-CoV-2 vaccination.
Hieber ML; Sprute R; Eichenauer DA; Hallek M; Jachimowicz RD
Infection; 2022 Oct; 50(5):1399-1404. PubMed ID: 35218512
[TBL] [Abstract][Full Text] [Related]
8. Safe usage of anakinra and dexamethasone to treat refractory hemophagocytic lymphohistiocytosis secondary to acute disseminated histoplasmosis in a patient with HIV/AIDS.
Ocon AJ; Bhatt BD; Miller C; Peredo RA
BMJ Case Rep; 2017 Oct; 2017():. PubMed ID: 28978596
[TBL] [Abstract][Full Text] [Related]
9. JAK/STAT pathway inhibition sensitizes CD8 T cells to dexamethasone-induced apoptosis in hyperinflammation.
Meyer LK; Verbist KC; Albeituni S; Scull BP; Bassett RC; Stroh AN; Tillman H; Allen CE; Hermiston ML; Nichols KE
Blood; 2020 Aug; 136(6):657-668. PubMed ID: 32530039
[TBL] [Abstract][Full Text] [Related]
10. [Ruxolitinib as an effective treatment for panniculitis associated hemophagocytic syndrome: A report of 2 cases and literature review].
Li GM; Jin YB; Gan YZ; Chen C; Jia Y; Li C
Beijing Da Xue Xue Bao Yi Xue Ban; 2022 Dec; 54(6):1208-1213. PubMed ID: 36533357
[TBL] [Abstract][Full Text] [Related]
11. Emapalumab for the treatment of relapsed/refractory hemophagocytic lymphohistiocytosis.
Vallurupalli M; Berliner N
Blood; 2019 Nov; 134(21):1783-1786. PubMed ID: 31537529
[TBL] [Abstract][Full Text] [Related]
12. Hemophagocytic lymphohistiocytosis secondary to virus infection and followed by lupus nephritis recurrence in a renal transplantation pediatric recipient: a case report.
Li J; Gao C; Zhu X; Yang D; Mao W; Yao H; Deng M; Tan L; Dai H; Xie X; Peng L; Peng F
BMC Nephrol; 2023 Jul; 24(1):200. PubMed ID: 37400798
[TBL] [Abstract][Full Text] [Related]
13. Hyperferritinemia as the diagnostic clue in life-threatening hemophagocytic lymphohistiocytosis.
Kerzel S; Zemlin M; Kömhoff M; Klaus G; Maier RF
Klin Padiatr; 2009 Sep; 221(5):318-21. PubMed ID: 19199227
[TBL] [Abstract][Full Text] [Related]
14. Hemophagocytic lymphohistiocytosis in COVID-19: Case reports of a stepwise approach.
Schnaubelt S; Tihanyi D; Strassl R; Schmidt R; Anders S; Laggner AN; Agis H; Domanovits H
Medicine (Baltimore); 2021 Mar; 100(12):e25170. PubMed ID: 33761694
[TBL] [Abstract][Full Text] [Related]
15. Therapeutic role of anakinra, an interleukin-1 receptor antagonist, in the management of secondary hemophagocytic lymphohistiocytosis/sepsis/multiple organ dysfunction/macrophage activating syndrome in critically ill children*.
Rajasekaran S; Kruse K; Kovey K; Davis AT; Hassan NE; Ndika AN; Zuiderveen S; Birmingham J
Pediatr Crit Care Med; 2014 Jun; 15(5):401-8. PubMed ID: 24583503
[TBL] [Abstract][Full Text] [Related]
16. Is COVID-19-associated cytokine storm distinct from non-COVID-19 secondary hemophagocytic lymphohistiocytosis?
Liu JM; Chi J
Exp Biol Med (Maywood); 2022 Feb; 247(4):330-337. PubMed ID: 35068219
[TBL] [Abstract][Full Text] [Related]
17. Hemophagocytic Lymphohistiocytosis in Renal Transplant Recipients: A 2-Case Report.
Mascia G; Argiolas D; Carta E; Ibba S; Piredda GB
Transplant Proc; 2020 Jun; 52(5):1566-1569. PubMed ID: 32389490
[TBL] [Abstract][Full Text] [Related]
18. A Case of Chronic Lymphocytic Leukemia Complicated by Hemophagocytic Lymphohistiocytosis: Identifying the Aberrant Immune Response.
Zoref-Lorenz A; Yuklea M; Topaz G; Jordan MB; Ellis M
J Gen Intern Med; 2022 May; 37(6):1542-1546. PubMed ID: 35178648
[TBL] [Abstract][Full Text] [Related]
19. Salvage therapy for refractory hemophagocytic lymphohistiocytosis: A review of the published experience.
Marsh RA; Jordan MB; Talano JA; Nichols KE; Kumar A; Naqvi A; Vaiselbuh SR;
Pediatr Blood Cancer; 2017 Apr; 64(4):. PubMed ID: 27786410
[TBL] [Abstract][Full Text] [Related]
20. Emapalumab for the treatment of hemophagocytic lymphohistiocytosis.
Cheloff AZ; Al-Samkari H
Drugs Today (Barc); 2020 Jul; 56(7):439-446. PubMed ID: 32648854
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]